Search research articles
Contact Us
Filters
Showing results (181-190 of 192) with videos related to
Page
of 20
Sort By:
Journal of Medicinal Chemistry
|
December 24, 1997
Peptidomimetic inhibitors of the human cytomegalovirus protease
W Ogilvie, M Bailey, M A Poupart, et al.
Antimicrobial Agents and Chemotherapy
|
March 26, 2014
Preclinical profile of BI 224436, a novel HIV-1 non-catalytic-site integrase inhibitor
Craig Fenwick, Ma'an Amad, Murray D Bailey, et al.
Angewandte Chemie (International Ed. in English)
|
May 6, 2015
Concise and Practical Asymmetric Synthesis of a Challenging Atropisomeric HIV Integrase Inhibitor
Keith R Fandrick, Wenjie Li, Yongda Zhang, et al.
Nature
|
October 28, 2003
An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus
Daniel Lamarre, Paul C Anderson, Murray Bailey, et al.
The AAPS Journal
|
July 11, 2024
Neutralizing Antibody Sample Testing and Report Harmonization
Darshana Jani, Michele Gunsior, Robin Marsden, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1
Lee D Fader, Eric Malenfant, Mathieu Parisien, et al.
Annals of Surgical Oncology
|
March 10, 2012
Management of the neck in the setting of definitive chemoradiation: is there a consensus? A GETTEC study
Juliette Thariat, Marc Hamoir, Renaud Garrel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 15, 2024
Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society
Nicolas Collongues, Françoise Durand-Dubief, Christine Lebrun-Frenay, et al.
The AAPS Journal
|
July 8, 2023
Neutralizing Antibody Validation Testing and Reporting Harmonization
Heather Myler, João Pedras-Vasconcelos, Todd Lester, et al.
JAMA Neurology
|
June 27, 2020
Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis
Céline Louapre, Nicolas Collongues, Bruno Stankoff, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 192) with videos related to
Sort By:
Page
of 20
Journal of Medicinal Chemistry
|
December 24, 1997
Peptidomimetic inhibitors of the human cytomegalovirus protease
W Ogilvie, M Bailey, M A Poupart, et al.
Antimicrobial Agents and Chemotherapy
|
March 26, 2014
Preclinical profile of BI 224436, a novel HIV-1 non-catalytic-site integrase inhibitor
Craig Fenwick, Ma'an Amad, Murray D Bailey, et al.
Angewandte Chemie (International Ed. in English)
|
May 6, 2015
Concise and Practical Asymmetric Synthesis of a Challenging Atropisomeric HIV Integrase Inhibitor
Keith R Fandrick, Wenjie Li, Yongda Zhang, et al.
Nature
|
October 28, 2003
An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus
Daniel Lamarre, Paul C Anderson, Murray Bailey, et al.
The AAPS Journal
|
July 11, 2024
Neutralizing Antibody Sample Testing and Report Harmonization
Darshana Jani, Michele Gunsior, Robin Marsden, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1
Lee D Fader, Eric Malenfant, Mathieu Parisien, et al.
Annals of Surgical Oncology
|
March 10, 2012
Management of the neck in the setting of definitive chemoradiation: is there a consensus? A GETTEC study
Juliette Thariat, Marc Hamoir, Renaud Garrel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 15, 2024
Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society
Nicolas Collongues, Françoise Durand-Dubief, Christine Lebrun-Frenay, et al.
The AAPS Journal
|
July 8, 2023
Neutralizing Antibody Validation Testing and Reporting Harmonization
Heather Myler, João Pedras-Vasconcelos, Todd Lester, et al.
JAMA Neurology
|
June 27, 2020
Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis
Céline Louapre, Nicolas Collongues, Bruno Stankoff, et al.
Page
of 20